Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Clinical trial NCT00835120 · COMPLETED

Trial details

NCT number: NCT00835120
Sponsor: University Hospitals Cleveland Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Syndrome Bipolar Depression Insulin Resistance

Start date: 2009-03-01
Primary completion: 2013-04-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.